Showing results (31-40 of 81) with videos related to
Sort By:
Pageof 9
Arthritis and Rheumatism|December 1, 2011
Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritisDenis Poddubnyy, Hildrun Haibel, Joachim Listing, et al.Annals of the Rheumatic Diseases|March 31, 2012
Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception CohortDenis Poddubnyy, Martin Rudwaleit, Hildrun Haibel, et al.Therapeutic Advances in Musculoskeletal Disease|April 2, 2021
Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trialFabian Proft, Anja Weiß, Murat Torgutalp, et al.RMD Open|December 31, 2024
Biomarkers reflecting disturbed gut barrier under treatment with TNF inhibitors in radiographic axial spondyloarthritisJudith Rademacher, Murat Torgutalp, Christine Maria Hempel, et al.Arthritis & Rheumatology (Hoboken, N.J.)|November 28, 2025
The impact of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: 10-year results from an inception cohortMurat Torgutalp, Valeria Rios Rodriguez, Fabian Proft, et al.Rheumatology (Oxford, England)|March 20, 2024
Impact of body composition on clinical outcomes in patients with active radiographic axial spondyloarthritis under biological therapyValeria Rios Rodriguez, Murat Torgutalp, Fabian Proft, et al.The Journal of Rheumatology|October 9, 2007
In vitro observations of T cell responsiveness to recall antigens during tumor necrosis factor-alpha-blocking therapy in patients with ankylosing spondylitisHeiner Appel, Rebecca Scheer, Hildrun Haibel, et al.The Journal of Rheumatology|February 3, 2016
Comparison of Clinical Examination versus Whole-body Magnetic Resonance Imaging of Enthesitis in Patients with Early Axial Spondyloarthritis during 3 Years of Continuous Etanercept TreatmentChristian E Althoff, Joachim Sieper, In-Ho Song, et al.Rheumatology (Oxford, England)|August 20, 2025
Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational studyDenis Poddubnyy, Joachim Sieper, Servet Akar, et al.Frontiers in Immunology|January 22, 2026
TAFRO syndrome requiring combined IL 6 and IL 1 inhibition: a case reportAhmad Wael Sultan, Eva Grießhammer, Carl Hinrichs, et al.Pageof 9